New York Life Investment Management LLC purchased a new stake in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 73,815 shares of the company’s stock, valued at approximately $483,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in OSCR. Southeastern Asset Management Inc. TN boosted its stake in Oscar Health by 30.8% in the 4th quarter. Southeastern Asset Management Inc. TN now owns 14,576,904 shares of the company’s stock worth $35,859,000 after purchasing an additional 3,430,032 shares during the period. Capital World Investors bought a new position in Oscar Health in the 1st quarter worth about $27,427,000. State Street Corp grew its position in shares of Oscar Health by 512.6% during the 2nd quarter. State Street Corp now owns 2,069,734 shares of the company’s stock worth $8,796,000 after buying an additional 1,731,860 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Oscar Health by 13.4% during the third quarter. Vanguard Group Inc. now owns 11,215,680 shares of the company’s stock valued at $55,966,000 after buying an additional 1,329,461 shares during the period. Finally, BlackRock Inc. lifted its stake in Oscar Health by 18.2% in the third quarter. BlackRock Inc. now owns 8,431,359 shares of the company’s stock worth $42,071,000 after acquiring an additional 1,298,904 shares during the period. Hedge funds and other institutional investors own 67.61% of the company’s stock.
Oscar Health Price Performance
Oscar Health stock opened at $7.56 on Wednesday. The business has a 50 day simple moving average of $8.11 and a 200-day simple moving average of $6.57. Oscar Health, Inc. has a 12 month low of $2.05 and a 12 month high of $9.89. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.21 and a current ratio of 1.21.
Wall Street Analyst Weigh In
A number of brokerages recently commented on OSCR. Morgan Stanley reissued an “equal weight” rating and issued a $5.00 price objective on shares of Oscar Health in a research note on Friday, July 14th. Bank of America upgraded Oscar Health from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $5.40 to $8.75 in a research note on Tuesday, June 6th. Credit Suisse Group boosted their target price on shares of Oscar Health from $7.00 to $8.50 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Finally, The Goldman Sachs Group lifted their price objective on shares of Oscar Health from $5.50 to $7.50 and gave the stock a “neutral” rating in a research report on Thursday, August 10th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $6.11.
Read Our Latest Report on OSCR
Insider Transactions at Oscar Health
In other Oscar Health news, CAO Victoria Baltrus sold 5,267 shares of the stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $7.15, for a total value of $37,659.05. Following the completion of the transaction, the chief accounting officer now directly owns 37,288 shares of the company’s stock, valued at $266,609.20. The sale was disclosed in a filing with the SEC, which is available at this link. In other Oscar Health news, EVP Ranmali Bopitiya sold 11,597 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $7.15, for a total transaction of $82,918.55. Following the transaction, the executive vice president now owns 81,313 shares of the company’s stock, valued at approximately $581,387.95. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Victoria Baltrus sold 5,267 shares of the stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $7.15, for a total transaction of $37,659.05. Following the transaction, the chief accounting officer now owns 37,288 shares in the company, valued at $266,609.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 169,373 shares of company stock worth $1,211,017. Corporate insiders own 25.54% of the company’s stock.
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.
Featured Stories
- Five stocks we like better than Oscar Health
- What Are Utility Stocks? An Overview of the Utilities Sector
- On Holding Slips Into A More Comfortable Price PointÂ
- Overbought Stocks Explained: Should You Trade Them?
- 3 Growing Cannabis Stocks Ready To Bloom
- Golden Cross Stocks: Pattern, Examples and Charts
- Will Meta’s Pullback Offer Buy Point After AI-Driven Surge?
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
